ANTM Stock Overview
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$399.74|
|52 Week High||US$439.90|
|52 Week Low||US$286.04|
|1 Month Change||-4.87%|
|3 Month Change||5.55%|
|1 Year Change||23.75%|
|3 Year Change||39.08%|
|5 Year Change||172.66%|
|Change since IPO||1,854.72%|
Recent News & Updates
Anthem, Inc. (NYSE:ANTM) Shares Could Be 21% Below Their Intrinsic Value Estimate
Today we will run through one way of estimating the intrinsic value of Anthem, Inc. ( NYSE:ANTM ) by taking the...
Why Anthem's (NYSE:ANTM) has the Fundamental Potential to Keep Delivering on the Long-Term
Anthem, Inc. (NYSE:ANTM) seems to have been a great long-term investment, as evident by the stock being up 257% in five years. Additionally, the share price has risen 14% in thirty days, resulting from the latest earnings release. We will go over the performance of the bottom line as it relates to providing free cash flows to investors, and see how the future potential fares.
|ANTM||US Healthcare||US Market|
Return vs Industry: ANTM exceeded the US Healthcare industry which returned 14.6% over the past year.
Return vs Market: ANTM exceeded the US Market which returned 17.8% over the past year.
|ANTM Average Weekly Movement||4.0%|
|Healthcare Industry Average Movement||6.7%|
|Market Average Movement||6.1%|
|10% most volatile stocks in US Market||14.9%|
|10% least volatile stocks in US Market||2.4%|
Stable Share Price: ANTM is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: ANTM's weekly volatility (4%) has been stable over the past year.
About the Company
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.
Anthem Fundamentals Summary
|ANTM fundamental statistics|
Is ANTM overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ANTM income statement (TTM)|
|Cost of Revenue||US$99.20b|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
Jan 26, 2022
|Earnings per share (EPS)||22.73|
|Net Profit Margin||4.12%|
How did ANTM perform over the long term?See historical performance and comparison
1.1%Current Dividend Yield
Does ANTM pay a reliable dividends?See ANTM dividend history and benchmarks
|Anthem dividend dates|
|Ex Dividend Date||Dec 02 2021|
|Dividend Pay Date||Dec 21 2021|
|Days until Ex dividend||2 days|
|Days until Dividend pay date||17 days|
Does ANTM pay a reliable dividends?See ANTM dividend history and benchmarks
Is Anthem undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ANTM ($399.74) is trading below our estimate of fair value ($538.27)
Significantly Below Fair Value: ANTM is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ANTM is good value based on its PE Ratio (17.6x) compared to the US Healthcare industry average (20.5x).
PE vs Market: ANTM is poor value based on its PE Ratio (17.6x) compared to the US market (16.6x).
Price to Earnings Growth Ratio
PEG Ratio: ANTM is poor value based on its PEG Ratio (1.9x)
Price to Book Ratio
PB vs Industry: ANTM's PB Ratio (2.7x) is in line with the US Healthcare industry average.
How is Anthem forecast to perform in the next 1 to 3 years based on estimates from 17 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ANTM's forecast earnings growth (9.3% per year) is above the savings rate (2%).
Earnings vs Market: ANTM's earnings (9.3% per year) are forecast to grow slower than the US market (14.3% per year).
High Growth Earnings: ANTM's earnings are forecast to grow, but not significantly.
Revenue vs Market: ANTM's revenue (8.3% per year) is forecast to grow slower than the US market (10.1% per year).
High Growth Revenue: ANTM's revenue (8.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ANTM's Return on Equity is forecast to be low in 3 years time (16.7%).
How has Anthem performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ANTM has high quality earnings.
Growing Profit Margin: ANTM's current net profit margins (4.1%) are lower than last year (4.2%).
Past Earnings Growth Analysis
Earnings Trend: ANTM's earnings have grown by 12.9% per year over the past 5 years.
Accelerating Growth: ANTM's earnings growth over the past year (11.4%) is below its 5-year average (12.9% per year).
Earnings vs Industry: ANTM earnings growth over the past year (11.4%) underperformed the Healthcare industry 32.5%.
Return on Equity
High ROE: ANTM's Return on Equity (15.4%) is considered low.
How is Anthem's financial position?
Financial Position Analysis
Short Term Liabilities: ANTM's short term assets ($51.9B) exceed its short term liabilities ($35.2B).
Long Term Liabilities: ANTM's short term assets ($51.9B) exceed its long term liabilities ($27.1B).
Debt to Equity History and Analysis
Debt Level: ANTM has more cash than its total debt.
Reducing Debt: ANTM's debt to equity ratio has reduced from 68.6% to 63.6% over the past 5 years.
Debt Coverage: ANTM's debt is well covered by operating cash flow (46.1%).
Interest Coverage: ANTM's interest payments on its debt are well covered by EBIT (10x coverage).
What is Anthem current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ANTM's dividend (1.13%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.37%).
High Dividend: ANTM's dividend (1.13%) is low compared to the top 25% of dividend payers in the US market (3.69%).
Stability and Growth of Payments
Stable Dividend: ANTM's dividends per share have been stable in the past 10 years.
Growing Dividend: ANTM's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (19.3%), ANTM's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: ANTM's dividends in 3 years are forecast to be well covered by earnings (19.5% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Gail Boudreaux (60 yo)
Ms. Gail Koziara Boudreaux serves as Director at Target Corporation since September 23, 2021. She has been President, Chief Executive Officer and Director of Anthem, Inc. since November 11, 2017. Prior to...
CEO Compensation Analysis
Compensation vs Market: Gail's total compensation ($USD17.11M) is above average for companies of similar size in the US market ($USD11.11M).
Compensation vs Earnings: Gail's compensation has been consistent with company performance over the past year.
Experienced Management: ANTM's management team is seasoned and experienced (5.8 years average tenure).
Experienced Board: ANTM's board of directors are considered experienced (8.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ANTM insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Anthem, Inc.'s employee growth, exchange listings and data sources
- Name: Anthem, Inc.
- Ticker: ANTM
- Exchange: NYSE
- Founded: 1944
- Industry: Managed Health Care
- Sector: Healthcare
- Market Cap: US$98.214b
- Shares outstanding: 242.71m
- Website: https://www.antheminc.com
Number of Employees
- Anthem, Inc.
- 220 Virginia Avenue
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/12/02 23:31|
|End of Day Share Price||2021/12/02 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.